eLetters

73 e-Letters

published between 2006 and 2009

  • The quality of sero-surveillance in low and middle income countries
    Jacqueline P Duncan

    Dear Editor,

    Lyerla et al (August 2008 issue) conclude that there is a general overall weakness in the surveillance system of most low and middle income countries in their article on the quality of sero-surveillance. This may well be the case. However, the paper has some important inaccuracies and some of their assertions can be challenged. Their assessment that Jamaica has a poorly functioning surveillance syste...

    Show More
  • Reply regarding confidentiality and the human touch
    Emma J Lim

    Dear Editor,

    With regard to your concerns about losing the human touch and confidentiality issues with your patients, our full text article explains the following:

    1. All patients are given a preference on how they would like us to communicate results to them, by phone, text or letter. We found the majority preferred text message as the patients believed it led to the highest degree of confidentiality and ens...

    Show More
  • Genomicizing Behavioral HIV Prevention: Next Steps
    Rhonda Rosenberg

    Dear Editor,

    The study reported by Brown et al 1. underscores the urgent need for targeted testing and supportive strategies of opt-out testing and post-exposure prophylaxis. We agree with the editorial review by Steckler & Golden 2., recommending more aggressive analysis of why testing is accepted/rejected or offered/not pursued by providers; however, we would add a further strategy for the field to consider. Wh...

    Show More
  • Confidentiality concerns
    Susan H Dubb

    Dear Editor,

    Although the concern to contact patients as soon as possible after the diagnosis is made to initiate treatment and prevent further spread is of great importance, I'm concerned about the possibility of patient confidentiality, and the loss of the human touch.

    More and more we are becoming dependant on the latest pieces of technology to transmit information, rather than direct interaction with th...

    Show More
  • Not false positive tests- Just different populations
    Guduru Gopal Rao

    Dear Editor

    In their letter Aghaizu et al suggest that the differences in the prevalence in their study 1 and our study 2may be attributable to false positive tests using strand displacement assay (ProbeTec, Becton Dickenson). We disagree with these observations. We would like to point out that the populations studied were substantially different- majority of our subjects attended sexual health and reproduction clinics...

    Show More
  • Missing PID: Is it a reflection of training?
    Ranjana Rani

    Dear Editor,

    This report confirms that PID can be often be missed clinically. Other than lowering the threshold for diagnosis, there could be other ways of improving diagnosis of PID. Training background may have contributed to the different rate of diagnosis among doctors. It would be important to review whether high diagnosing doctors were more likely to have had gynaecology training compared with low diagnosing d...

    Show More
  • Re: Why do people decline HIV testing?
    Helen L Munro

    Dear Editor,

    In response to M O Ramogi on 21st August 2008, it is important to point out that since only patients attending with a new episode were included in the study, those experiencing chronic/recurrent infections or attending solely for treatment were excluded. Therefore the inclusion of patients for who HIV testing is less applicable is unlikely to be the explanation for the association between symptoms of an STI...

    Show More
  • Screening for genital and anorectal sexually transmitted infections in HIV prevention trials in Afri
    Marianne L. Grijsen

    Dear Dr. Potterat and colleagues,

    Thank you for responding to our manuscript. We have carefully reviewed your comments. Below, please find our responses to the questions raised.

    The first comment raised concerns the fact that “sexual factors may have played a lesser role in observed HIV and syphilis prevalence’s than nonsexual factors.” The sexual transmission of sexually transmitted infections including HI...

    Show More
  • Why do people decline HIV testing?
    Manjula Pammi

    Dear Editor,

    Although the uptake of the HIV test has increased significantly in recent years, following the introduction of opt-out screening programmes, there is still a substantial number of the HIV population that is still undiagnosed.1 Therefore, we read with interest the National study of HIV testing in men who have sex with men attending genitourinary clinics in the United Kingdom by H L Munro et el.2 This st...

    Show More
  • HPV Vaccination: Ethical imperatives and clinical indications for Gardasil
    Peter Greenhouse

    Dear Editor,

    In supporting Colm O’Mahony’s editorial (1), I would like to amplify Karen Rogstad’s concern (2) about the unwitting creation of a two-tier healthcare system for HPV vaccination and the social discord which will inevitably result from the Government’s decision.

    Any well-informed parent of sufficient means would want to protect their children against genital warts, so their daughters will necessa...

    Show More

Pages